Clinical trial

Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening…

NCT00434616 · Franziskus-Krankenhaus, Other · Unknown status

Key facts

NCT number NCT00434616
Title Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia
Official title Security and Effectiveness of Autologous Bone Marrow Stem Cell Transplantation to Avoid Amputations in Patients With Limb-threatening Ischemia: A Multicentric Randomized Placebo-controlled Double-blind Study
Acronym BONMOT
Lead sponsor Franziskus-Krankenhaus, Other
Collaborators Klinikum Karlsbad-Langensteinbach Stiftungsklinikum Boppard Krankenhaus der Barmherzigen Brüder Trier
Status Unknown status
Phase Phase 2/Phase 3
Study type Interventional
Conditions Peripheral Vascular Disease, Diabetic Foot, Peripheral Arterial Occlusive Disease, Leg Ulcer, Gangrene, Ischemia
Intervention type Biological, Procedure
Interventions Autologous bone marrow cell concentrate transplantation, saline injection
Enrollment 90
Start date Apr 1, 2007
Primary completion Apr 1, 2011
Completion Jul 1, 2011
First posted Feb 13, 2007
Last update posted Apr 6, 2011
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies